Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report19 September 2018
The US and UK governments have signed a civil Nuclear Energy Research and Development Action Plan.
On 13 September 2018, representatives from the US Department of Energy (DOE) and the UK’s Department for Business, Energy and Industrial Strategy (BEIS) met at the British Embassy in Washington, DC to sign the Action Plan, during a US-UK nuclear roundtable discussion.
The aim of the action plan is ensure nuclear energy’s contribution to both countries’ strategic energy resources, low carbon emissions targets, nonproliferation goals and nuclear energy safety.
Melissa Mann Executive Director, Strategic and Government Affairs, attended the roundtable discussion and signing ceremony on behalf of Urenco and said:
"The action plan demonstrates further international collaboration and cooperation between the US and UK Governments in respect to the nuclear industry.”
The action plan calls for working groups on the following areas: radioisotopes for use in space technologies; nuclear reactor technologies; advanced fuels; fuel cycle technologies; advanced modelling and simulation and enabling technologies.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries